Angion Biomedica Corp.
51 Charles Lindbergh Blvd.
Uniondale
New York
11553
United States
Tel: (516) 326-1200
Website: http://www.angion.com/
47 articles with Angion Biomedica Corp.
-
Angion Biomedica Corp. To Present Clinical And Preclinical Data At The Upcoming American Society of Nephrology Conference In San Diego
11/2/2015
-
Angion Biomedica Corp. To Commence Phase 2 Clinical Trial Of BB3 In Acute Kidney Injury
6/9/2015
-
Angion Biomedica Corp. Advances BB3 Into Pivotal Phase 3 Clinical Trial In Renal Transplant Patients With Delayed Graft Function
5/14/2015
-
Organ Recovery Biotech Angion Biomedica Corp. Files For A $35 Million IPO
4/15/2014
-
First Patient Treated in Angion Biomedica Corp.'s Phase II BB3 Heart Attack Clinical Trial
7/19/2012
-
Angion Biomedica Corp. Receives Fast Track and Orphan Drug Product Designations from FDA for its Lead Therapeutic, BB3
7/6/2010
-
Angion Biomedica Corp. Has Signed Licensing Option With Memorial Sloan-Kettering Cancer Center For Novel Vaccine Platform
1/8/2009